Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Hennessy

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
JAMA Cardiology|May 20, 2026
Structural Assumptions in Semaglutide Cost-Effectiveness-ReplySusan Hennessy, Sadiya S Khan, Dhruv S Kazi
Mental Health in Family Medicine|April 6, 2012
Patients' experiences of receiving collaborative care for the treatment of depression in the UK: a qualitative investigationAngela Simpson, David Richards, Linda Gask, et al.
Hormone Research|August 17, 2005
Quality of life assessment of growth hormone deficiency in adults (QoL-AGHDA): comparison of normative reference data for the general population of England and Wales with results for adult hypopituitary patients with growth hormone deficiencyMaria Kołtowska-Haggstrom, Susan Hennessy, Anders F Mattsson, et al.
Pharmacoeconomics|September 8, 2025
Highlights from the Manifesto on the Health Economics of Cardiovascular Disease PreventionZanfina Ademi, Sheridan E Rodda, Karl Vivoda, et al.
Cartilage|May 13, 2020
Osteochondral Autograft Plugs versus Paste Graft: <i>Ex Vivo</i> Morselization Increases Chondral Matrix ProductionDaniel Grande, Todd Goldstein, Thomas J Turek, et al.
Circulation. Cardiovascular Quality and Outcomes|August 19, 2025
Cost-Effectiveness of Hypertension Treatment According to 2017 American College of Cardiology and American Heart Association GuidelinesJoanne M Penko, Brandon K Bellows, Susan Hennessy, et al.
Medrxiv : the Preprint Server for Health Sciences|January 18, 2024
Projected Impact of Nonpharmacologic Management of Stage 1 Hypertension Among Lower-Risk US AdultsKendra D Sims, Pengxiao Carol Wei, Joanne M Penko, et al.
Hypertension (Dallas, Tex. : 1979)|June 17, 2024
Projected Impact of Nonpharmacologic Management of Stage 1 Hypertension Among Lower-Risk US AdultsKendra D Sims, Pengxiao Carol Wei, Joanne M Penko, et al.
JAMA Cardiology|February 4, 2026
Cost-Effectiveness of Semaglutide for Secondary Prevention of Cardiovascular Disease in US AdultsSusan Hennessy, Joanne Penko, Brandon K Bellows, et al.
Journal of the American College of Cardiology|September 26, 2025
2025 AHA/ACC Statement on Cost/Value Methodology in Clinical Practice Guidelines (Update From 2014 Statement): A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesDhruv S Kazi, Abdul R Abdullah, Suzanne V Arnold, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
JAMA Cardiology|May 20, 2026
Structural Assumptions in Semaglutide Cost-Effectiveness-ReplySusan Hennessy, Sadiya S Khan, Dhruv S Kazi
Mental Health in Family Medicine|April 6, 2012
Patients' experiences of receiving collaborative care for the treatment of depression in the UK: a qualitative investigationAngela Simpson, David Richards, Linda Gask, et al.
Hormone Research|August 17, 2005
Quality of life assessment of growth hormone deficiency in adults (QoL-AGHDA): comparison of normative reference data for the general population of England and Wales with results for adult hypopituitary patients with growth hormone deficiencyMaria Kołtowska-Haggstrom, Susan Hennessy, Anders F Mattsson, et al.
Pharmacoeconomics|September 8, 2025
Highlights from the Manifesto on the Health Economics of Cardiovascular Disease PreventionZanfina Ademi, Sheridan E Rodda, Karl Vivoda, et al.
Cartilage|May 13, 2020
Osteochondral Autograft Plugs versus Paste Graft: <i>Ex Vivo</i> Morselization Increases Chondral Matrix ProductionDaniel Grande, Todd Goldstein, Thomas J Turek, et al.
Circulation. Cardiovascular Quality and Outcomes|August 19, 2025
Cost-Effectiveness of Hypertension Treatment According to 2017 American College of Cardiology and American Heart Association GuidelinesJoanne M Penko, Brandon K Bellows, Susan Hennessy, et al.
Medrxiv : the Preprint Server for Health Sciences|January 18, 2024
Projected Impact of Nonpharmacologic Management of Stage 1 Hypertension Among Lower-Risk US AdultsKendra D Sims, Pengxiao Carol Wei, Joanne M Penko, et al.
Hypertension (Dallas, Tex. : 1979)|June 17, 2024
Projected Impact of Nonpharmacologic Management of Stage 1 Hypertension Among Lower-Risk US AdultsKendra D Sims, Pengxiao Carol Wei, Joanne M Penko, et al.
JAMA Cardiology|February 4, 2026
Cost-Effectiveness of Semaglutide for Secondary Prevention of Cardiovascular Disease in US AdultsSusan Hennessy, Joanne Penko, Brandon K Bellows, et al.
Journal of the American College of Cardiology|September 26, 2025
2025 AHA/ACC Statement on Cost/Value Methodology in Clinical Practice Guidelines (Update From 2014 Statement): A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesDhruv S Kazi, Abdul R Abdullah, Suzanne V Arnold, et al.
Pageof 2